- ►annals.org [PDF] SB Woo, JW Hellstein, JR Kalmar - Annals of Internal Medicine, 2006 - Am Coll Physicians Osteonecrosis of the jaws is a recently described adverse side effect of
bisphosphonate therapy. Patients with multiple myeloma and metastatic carcinoma
to the skeleton who are receiving intra- venous, nitrogen-containing ... Cited by 250 - Related articles - BL Direct - All 7 versions
- ►tripod.com [PDF] RE Marx, Y Sawatari, M Fortin, V Broumand - Journal of oral and maxillofacial surgery, 2005 - Elsevier Professor of Surgery and Chief, University of Miami Miller School of Medicine,
Division of Oral and Maxillofacial Surgery, Miami, FL. ... †Private
Practice, Oral Surgery, Miami, FL; Former Resident, University of Miami ... Cited by 418 - Related articles - BL Direct - All 34 versions
- ►ascopubs.org A Bamias, E Kastritis, C Bamia, LA … - Journal of Clinical Oncology, 2005 - jco.ascopubs.org RESULTS: Seventeen patients (6.7%) developed ONJ: 11 of 111 (9.9%) with multiple
myeloma, two of 70 (2.9%) with breast cancer, three of 46 (6.5%) with prostate
cancer, and one of 25 (4%) with other neoplasms (P = .289). The median ... Cited by 381 - Related articles - All 14 versions
A CA - CA A Cancer Journal for Clinicians - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 262 - Related articles - All 3 versions
- ►hyperbaricinformation.com [PDF] SL Ruggiero, B Mehrotra, TJ Rosenberg, SL … - Journal of oral and maxillofacial surgery, 2004 - Elsevier Bisphosphonates are widely used in the management of metastatic disease to the
bone and in the treatment of osteoporosis. We were struck in the past 3 years
with a cluster of patients with necrotic lesions in the jaw who shared 1 ... Cited by 738 - Related articles - All 19 versions
- ►shouxi.net BGM Durie, M Katz, J Crowley, SB Woo, K … - New England Journal of Medicine, 2005 - content.nejm.org In September 2004, Novartis, the manufacturer of pamidronate (Aredia) and
zoledronic acid (Zometa), issued post-marketing guidelines 3 for both drugs in
relation to osteonecrosis of the jaw that emphasized a particular risk with ... Cited by 286 - Related articles - All 8 versions
- ►ada.org CA Migliorati, J CASIGLIA, J EPSTEIN, PL … - The Journal of the American Dental Association, 2005 - Am Dental Assoc Results. There is strong evidence that bisphosphonate therapy is the common link
in patients with BON. The pathobiological mechanism leading to BON may have to
do with the inhibition of bone remodeling and decreased intraosseous blood ... Cited by 200 - Related articles - BL Direct - All 10 versions
- ►angrylapdog.com A Badros, D Weikel, A Salama, O Goloubeva, A … - Journal of Clinical Oncology, 2006 - jco.ascopubs.org.p.angrylapdog.com RESULTS: Patients usually presented with pain. ONJ occurred posterior to the
cuspids (n = 20) mostly in the mandible. Debridement and sequestrectomy with
primary closure were performed in 14 patients; of these, four patients had ... Cited by 214 - Related articles - All 11 versions
- ►ascopubs.org S Ruggiero, J Gralow, RE Marx, AO Hoff, MM … - Journal of oncology practice, 2006 - jop.ascopubs.org RESULTS: ONJ is a clinical entity with many possible etiologies; historically
identified risk factors include corticosteroids, chemotherapy, radiotherapy,
trauma, infection, and cancer. With emerging concern for potential ... Cited by 140 - Related articles - All 19 versions
RE Marx - Journal of Oral and Maxillofacial Surgery, 2003 - Elsevier To the Editor:—Preliminary to a manuscript submitted to a refereed scientific
journal, this preliminary communication is being issued by the Division of Oral
and Maxillofacial Surgery at the University of Miami School of Medicine. It ... Cited by 615 - Related articles - All 8 versions
